An atypical presentation of immune checkpoint inhibitor associated myositis with normal creatine kinase: a case report

Immune checkpoint inhibitors (ICIs) have been revolutionary in the field of cancer therapeutics. Myositis is a known rheumatic immunotherapy related adverse event with a fatality rate of 26.8% when associated with myasthenia gravis and 51.3% when associated with myocarditis. Typically, creatine kina...

Full description

Bibliographic Details

Published in:	Frontiers in Immunology
Main Authors:	Monika A. Satoskar, Anthony G. Mansour, Richard Wu, Yuanquan Yang, Mary H. Caldwell, Alexa S. Meara
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	immunotherapy immune checkpoint inhibitor myositis immune-related adverse event aldolase creatine kinase (CK)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2025.1661534/full